- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01028469
Artelon Metatarsophalangeal (MTP) Spacer
December 14, 2009 updated by: Artimplant AB
Artelon MTP Spacer - Surgical Treatment of Mild to Moderate Hallux Rigidus
The aim of this prospective, case series is to evaluate the surgical treatment of painful and disabling osteoarthrosis in the MTP-I joint by insertion of an Artelon MTP Spacer.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
15
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Martin Alund, M.D.
- Email: martin.alund@vgregion.se
Study Locations
-
-
-
Mölndal, Sweden
- Recruiting
- Sahlgrenska Universitetssjukhuset, Område Ortopedi, Mölndal
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The patient experiences pain and limitations of the great toe dorsiflexion at the MTP-I joint.
- The patient has a clinically and radiographically verified arthritis in the MTP-I joint indicating the need for surgical treatment.
- The patient reads, understands and is able to complete the study questionnaires in Swedish.
- The patient has received written and oral information regarding the study and has signed the informed consent form.
Exclusion criteria:
- The patient has a pronounced hallux rigidus without mobility in the MTP-I joint (ROM = 0°).
- The patient has previously received surgical treatment affecting the anatomy of the MTP-I joint.
- The patient has a systemic rheumatic disease, ongoing infection, hallux valgus or is seriously ill.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Artelon MTP Spacer
Metatarsophalageal hemi-implant
|
Metatarsophalangeal hemi-implant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain, function and alignment of the treated toe evaluated by the investigator using the American Orthopeadic Foot & Ankle Society (AOFAS) clinical rating system.
Time Frame: pre-treatment and 12 months post-op
|
pre-treatment and 12 months post-op
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Martin Alund, M.D., Sahlgrenska University Hospital, Mölndal, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2009
Primary Completion (ANTICIPATED)
December 1, 2011
Study Registration Dates
First Submitted
December 8, 2009
First Submitted That Met QC Criteria
December 8, 2009
First Posted (ESTIMATE)
December 9, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
December 15, 2009
Last Update Submitted That Met QC Criteria
December 14, 2009
Last Verified
December 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KP026
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis
-
Sanford HealthActive, not recruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder Osteoarthritis | Ankle Osteoarthritis | Wrist OsteoarthritisUnited States
-
University of EdinburghHospital for Special Surgery, New YorkRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited Kingdom
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
Medical University of WarsawUnknownOsteoarthritis | Knee Osteoarthritis | Hip Osteoarthritis | Glenohumeral OsteoarthritisPoland
-
University of California, San FranciscoStanford University; Robert Wood Johnson FoundationCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
Hospital for Special Surgery, New YorkRoyal Infirmary of EdinburghRecruitingKnee Osteoarthritis | Hip Osteoarthritis | Shoulder OsteoarthritisUnited States, United Kingdom
-
Ottawa Hospital Research InstituteNot yet recruitingKnee Osteoarthritis | Hip Osteoarthritis
-
University Hospital, LilleCompleted
-
Massachusetts General HospitalNewton-Wellesley Hospital; The New England Baptist HospitalCompletedKnee Osteoarthritis | Hip OsteoarthritisUnited States
Clinical Trials on Artelon MTP Spacer
-
Orthopedic Foot and Ankle Center, OhioArtimplant ABTerminatedAchilles Tendon RuptureUnited States
-
ASST Gaetano Pini-CTOUnknown
-
Stealth BioTherapeutics Inc.ICON Clinical ResearchCompletedReperfusion Injury | STEMIUnited States, Hungary, Germany, Poland
-
University of OuluOulu University HospitalTerminatedUrogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic NeoplasmsFinland
-
Stealth BioTherapeutics Inc.CompletedNormal and Impaired Renal FunctionUnited States
-
Stealth BioTherapeutics Inc.CompletedCongestive Heart FailureBulgaria
-
Globus Medical IncTerminatedLumbar Spinal StenosisUnited States
-
Stealth BioTherapeutics Inc.AvailableMitochondrial Diseases | Barth Syndrome
-
Stealth BioTherapeutics Inc.Withdrawn
-
Spineology, IncCompletedDegeneration of Lumbar Intervertebral DiscUnited States